Total Payments
$14,748
2024 Payments
$2,352
Companies
42
Transactions
970
Medicare Patients
2,191
Medicare Billing
$155,247
Payment Breakdown by Category
Food & Beverage$14,742 (100.0%)
Education$6.25 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,742 | 969 | 100.0% |
| Education | $6.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,225 | 100 | $0 (2024) |
| Novo Nordisk Inc | $1,933 | 188 | $0 (2024) |
| Lilly USA, LLC | $1,491 | 99 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,416 | 84 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,256 | 92 | $0 (2024) |
| PFIZER INC. | $929.33 | 78 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $684.20 | 36 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $626.67 | 44 | $0 (2023) |
| Abbott Laboratories | $572.64 | 47 | $0 (2024) |
| ABBVIE INC. | $422.39 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,352 | 126 | AstraZeneca Pharmaceuticals LP ($538.96) |
| 2023 | $1,907 | 120 | Novo Nordisk Inc ($441.57) |
| 2022 | $1,974 | 122 | Boehringer Ingelheim Pharmaceuticals, Inc. ($320.16) |
| 2021 | $1,670 | 123 | Boehringer Ingelheim Pharmaceuticals, Inc. ($234.48) |
| 2020 | $1,016 | 76 | AstraZeneca Pharmaceuticals LP ($214.58) |
| 2019 | $1,617 | 132 | GlaxoSmithKline, LLC. ($254.65) |
| 2018 | $2,052 | 127 | AstraZeneca Pharmaceuticals LP ($457.04) |
| 2017 | $2,160 | 144 | Boehringer Ingelheim Pharmaceuticals, Inc. ($381.75) |
All Payment Transactions
970 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $75.19 | General |
| Category: Diabetes Care | ||||||
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Diabetes Care | ||||||
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.68 | General |
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.71 | General |
| 12/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $123.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.93 | General |
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 552 | 830 | $82,184 | $44,290 |
| 2022 | 15 | 588 | 865 | $82,405 | $44,016 |
| 2021 | 12 | 464 | 685 | $65,921 | $36,990 |
| 2020 | 16 | 587 | 800 | $62,868 | $29,951 |
Total Patients
2,191
Total Services
3,180
Medicare Billing
$155,247
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 21 | $735.00 | $197.02 | 26.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 39 | 44 | $264.00 | $151.28 | 57.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 32 | 42 | $840.00 | $124.44 | 14.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 18 | 21 | $126.00 | $67.78 | 53.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 17 | 19 | $95.00 | $1.36 | 1.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 126 | 227 | $34,050 | $19,383 | 56.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 188 | $21,225 | $12,000 | 56.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 28 | 28 | $2,100 | $1,827 | 87.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,100 | $1,260 | 60.0% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 35 | 39 | $2,340 | $950.12 | 40.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 43 | 43 | $1,290 | $743.04 | 57.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 29 | 34 | $1,360 | $319.74 | 23.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 22 | 27 | $540.00 | $262.17 | 48.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 28 | 31 | $186.00 | $107.44 | 57.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 22 | 29 | $580.00 | $87.00 | 15.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 11 | 15 | $90.00 | $49.20 | 54.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 11 | 12 | $60.00 | $1.26 | 2.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 152 | 296 | $29,600 | $13,576 | 45.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 100 | 133 | $19,950 | $9,054 | 45.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 41 | 41 | $3,075 | $2,488 | 80.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $2,275 | $1,554 | 68.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 52 | 53 | $1,325 | $903.69 | 68.2% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 36 | 39 | $2,340 | $677.92 | 29.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 34 | 36 | $1,440 | $387.64 | 26.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 19 | 24 | $480.00 | $231.33 | 48.2% |
About Dr. Kevin Agrest, DO
Dr. Kevin Agrest, DO is a Family Medicine healthcare provider based in Warren, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386625606.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Agrest, DO has received a total of $14,748 in payments from pharmaceutical and medical device companies, with $2,352 received in 2024. These payments were reported across 970 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($14,742).
As a Medicare-enrolled provider, Agrest has provided services to 2,191 Medicare beneficiaries, totaling 3,180 services with total Medicare billing of $155,247. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Warren, MI
- Active Since 11/14/2005
- Last Updated 08/16/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386625606
Products in Payments
- FARXIGA (Drug) $974.06
- Ozempic (Drug) $926.27
- TRULICITY (Drug) $922.79
- TRELEGY ELLIPTA (Drug) $755.67
- JARDIANCE (Drug) $633.95
- XARELTO (Drug) $476.27
- BREZTRI (Drug) $420.37
- CHANTIX (Drug) $382.37
- Rybelsus (Drug) $353.25
- Kerendia (Drug) $351.71
- Vascepa (Drug) $288.30
- SYMBICORT (Drug) $279.31
- FREESTYLE LIBRE 3 (Device) $260.39
- SPIRIVA RESPIMAT (Drug) $259.00
- VRAYLAR (Drug) $244.57
- STIOLTO RESPIMAT (Drug) $242.11
- Truvada (Drug) $238.14
- AIRSUPRA (Drug) $237.29
- SOLIQUA (Drug) $210.16
- INVOKANA (Drug) $207.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warren
Ping Wang, Md, MD
Family Medicine — Payments: $127,206
Family Medicine $127,206
Dr. Jason Rupeka, Do, DO
Family Medicine — Payments: $65,540
Family Medicine $65,540
Dr. Jacob Bair, D.o, D.O
Family Medicine — Payments: $33,701
Family Medicine $33,701
Saroj Misra, Do, DO
Family Medicine — Payments: $29,024
Family Medicine $29,024
Dr. Jeffrey Kraft, Do, DO
Family Medicine — Payments: $14,482
Family Medicine $14,482
Dr. Kimberly Jackson, D.o, D.O
Family Medicine — Payments: $11,737
Family Medicine $11,737